CATX

Healthcare

Perspective Therapeutics, Inc.

$4.95-0.16 (-3.13%)

Prev Close

$5.11

Open

$5.12

High

$5.24

Low

$4.88

Volume

847.6K

Market Cap

$387.6M

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Perspective Therapeutics, Inc. (CATX) has been exclusively buying, with 6 insider purchases totaling $359.0K and 0 insider sales totaling $0.00. The most recent insider transaction was by Hunt Jonathan Robert (Chief Accounting Officer), who purchased $22.3K worth of shares on Nov 13, 2025. Perspective Therapeutics, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $387.6M.

Buys (12M)

$359.0K

Sells (12M)

$0.00

Net Activity

Net Buyer

$359.0K

Active Insiders

last 12 mo

CATX Price Chart

CATX Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value
Nov 13, 2025↗	Hunt Jonathan Robert	Chief Accounting Officer	Buy	11,000	$2.03	$22.3K
Nov 12, 2025↗	Williamson Robert F III	Director	Buy	9,498	$2.10	$19.9K
Mar 31, 2025↗	Woods Lori A	Director	Buy	23,475	$2.13	$50.0K
Mar 28, 2025↗	Graham Juan	Chief Financial Officer	Buy	33,333	$2.25	$74.9K
Mar 28, 2025↗	Spoor Johan M.	Chief Executive Officer	Buy	26,676	$2.24	$59.7K
Mar 28, 2025↗	Williamson Robert F III	Director	Buy	60,337	$2.19	$132.2K
Dec 4, 2024↗	HENSON HEIDI	Director	Buy	25,975	$3.85	$100.0K
Dec 4, 2024↗	Spoor Johan M.	CEO	Buy	8,000	$3.77	$30.1K
Nov 25, 2024↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	12,829	$3.82	$49.0K
Nov 25, 2024↗	Spoor Johan M.	CEO	Buy	26,500	$3.79	$100.5K
Nov 25, 2024↗	Williamson Robert F III	Director	Buy	6,266	$3.64	$22.8K
Jun 17, 2024↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	1,800	$9.82	$17.7K
Jun 14, 2024↗	Woods Lori A	Director	Buy	4,587	$10.90	$50.0K
Jun 13, 2024↗	Spoor Johan M.	CEO	Buy	100,000	$1.17	$117.4K
Jun 3, 2024↗	Woods Lori A	Director	Buy	34,246	$1.46	$50.0K
May 31, 2024↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	25,006	$1.40	$35.0K
May 31, 2024↗	Williamson Robert F III	Director	Buy	55,000	$1.38	$75.9K
May 29, 2024↗	Williamson Robert F III	Director	Buy	30,031	$1.33	$40.0K
Jan 30, 2024↗	Williamson Robert F III	Director	Buy	127,206	$0.71	$90.7K
Jan 26, 2024↗	Williamson Robert F III	Director	Buy	135,879	$0.58	$78.5K
Jan 24, 2024↗	Puhlmann Markus	Chief Medical Officer	Buy	280,000	$0.50	$139.9K
Jan 24, 2024↗	Williamson Robert F III	Director	Buy	51,996	$0.49	$25.5K
Dec 21, 2023↗	Williamson Robert F III	Director	Buy	3,663	$0.33	$1.2K
Dec 18, 2023↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	125,000	$0.26	$32.3K
Dec 18, 2023↗	Williamson Robert F III	Director	Buy	23,680	$0.29	$7.0K
Dec 15, 2023↗	Puhlmann Markus	Chief Medical Officer	Buy	595,425	$0.32	$188.7K
Dec 14, 2023↗	Woods Lori A	Director	Buy	185,200	$0.27	$50.0K
Dec 1, 2022↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	85,404	$0.38	$32.5K
Nov 15, 2022↗	Woods Lori A	CEO	Buy	100,000	$0.34	$33.5K
Jun 8, 2022↗	Austin Mark John	VP Finance/Prin Fin&Acct Offic	Buy	18,800	$0.29	$5.4K
Jun 7, 2022↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	39,000	$0.29	$11.2K
Jun 7, 2022↗	Woods Lori A	CEO	Buy	75,000	$0.30	$22.2K
Mar 12, 2021↗	Woods Lori A	CEO	Sell	24,038	$0.57	$13.7K

CATX Insider Buying Activity

The following table shows recent insider purchases of Perspective Therapeutics, Inc. (CATX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Nov 13, 2025↗	Hunt Jonathan Robert	Chief Accounting Officer	Buy	11,000	$2.03	$22.3K
Nov 12, 2025↗	Williamson Robert F III	Director	Buy	9,498	$2.10	$19.9K
Mar 31, 2025↗	Woods Lori A	Director	Buy	23,475	$2.13	$50.0K
Mar 28, 2025↗	Graham Juan	Chief Financial Officer	Buy	33,333	$2.25	$74.9K
Mar 28, 2025↗	Spoor Johan M.	Chief Executive Officer	Buy	26,676	$2.24	$59.7K
Mar 28, 2025↗	Williamson Robert F III	Director	Buy	60,337	$2.19	$132.2K
Dec 4, 2024↗	HENSON HEIDI	Director	Buy	25,975	$3.85	$100.0K
Dec 4, 2024↗	Spoor Johan M.	CEO	Buy	8,000	$3.77	$30.1K
Nov 25, 2024↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	12,829	$3.82	$49.0K
Nov 25, 2024↗	Spoor Johan M.	CEO	Buy	26,500	$3.79	$100.5K
Nov 25, 2024↗	Williamson Robert F III	Director	Buy	6,266	$3.64	$22.8K
Jun 17, 2024↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	1,800	$9.82	$17.7K
Jun 14, 2024↗	Woods Lori A	Director	Buy	4,587	$10.90	$50.0K
Jun 13, 2024↗	Spoor Johan M.	CEO	Buy	100,000	$1.17	$117.4K
Jun 3, 2024↗	Woods Lori A	Director	Buy	34,246	$1.46	$50.0K
May 31, 2024↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	25,006	$1.40	$35.0K
May 31, 2024↗	Williamson Robert F III	Director	Buy	55,000	$1.38	$75.9K
May 29, 2024↗	Williamson Robert F III	Director	Buy	30,031	$1.33	$40.0K
Jan 30, 2024↗	Williamson Robert F III	Director	Buy	127,206	$0.71	$90.7K
Jan 26, 2024↗	Williamson Robert F III	Director	Buy	135,879	$0.58	$78.5K
Jan 24, 2024↗	Puhlmann Markus	Chief Medical Officer	Buy	280,000	$0.50	$139.9K
Jan 24, 2024↗	Williamson Robert F III	Director	Buy	51,996	$0.49	$25.5K
Dec 21, 2023↗	Williamson Robert F III	Director	Buy	3,663	$0.33	$1.2K
Dec 18, 2023↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	125,000	$0.26	$32.3K
Dec 18, 2023↗	Williamson Robert F III	Director	Buy	23,680	$0.29	$7.0K
Dec 15, 2023↗	Puhlmann Markus	Chief Medical Officer	Buy	595,425	$0.32	$188.7K
Dec 14, 2023↗	Woods Lori A	Director	Buy	185,200	$0.27	$50.0K
Dec 1, 2022↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	85,404	$0.38	$32.5K
Nov 15, 2022↗	Woods Lori A	CEO	Buy	100,000	$0.34	$33.5K
Jun 8, 2022↗	Austin Mark John	VP Finance/Prin Fin&Acct Offic	Buy	18,800	$0.29	$5.4K
Jun 7, 2022↗	Hunt Jonathan Robert	Chief Financial Officer	Buy	39,000	$0.29	$11.2K
Jun 7, 2022↗	Woods Lori A	CEO	Buy	75,000	$0.30	$22.2K